Perspective Therapeutics CATX
NYSE CATX
$2.98 -0.14 (-4.49%)
As of: Sep 9, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Preferred Dividend Payments (2010 - 2020)

Perspective Therapeutics' (CATX) quarterly Preferred Dividend Payments came in at $3000.0 in Q3 2020, little changed year-over-year from $3000.0 in Q4 2019, and little changed quarter-over-quarter from $3000.0 in Q2 2020.

Analysis

Perspective Therapeutics (CATX) Preferred Dividend Payments (2010 - 2020) Analysis & Trends

Perspective Therapeutics has disclosed Preferred Dividend Payments across 11 years of filings, most recently posting $3000.0 for Q3 2020.

  • In Q3 2020, Preferred Dividend Payments changed 0.0% year-over-year to $3000.0; the TTM figure through Jun 2021 stood at $3000.0 (down 72.73% YoY), while the FY2021 annual figure was $3000.0, down 72.73% from the prior year.
  • Preferred Dividend Payments came in at $3000.0 for Q3 2020 at Perspective Therapeutics, roughly flat from $3000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $3000.0 in Q1 2016 to a low of $2000.0 in Q4 2016.
  • Average Preferred Dividend Payments over 5 years is $2842.1, with a median of $3000.0 recorded in 2016.
  • Year-over-year, Preferred Dividend Payments tumbled 33.33% in 2016 and surged 50.0% in 2017.
  • Over 5 years, Preferred Dividend Payments stood at $2000.0 in 2016, then surged by 50.0% to $3000.0 in 2017, then slumped by 33.33% to $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then surged by 50.0% to $3000.0 in 2020.
  • Per Business Quant data, the three most recent Preferred Dividend Payments figures were $3000.0 in Q3 2020, $3000.0 in Q2 2020, and $3000.0 in Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Perspective Therapeutics 358.23 Mn 358.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 3,000.00
Jun 30, 2020 3,000.00
Mar 31, 2020 3,000.00
Dec 31, 2019 2,000.00
Sep 30, 2019 3,000.00
Jun 30, 2019 3,000.00
Mar 31, 2019 3,000.00
Dec 31, 2018 2,000.00
Sep 30, 2018 3,000.00
Jun 30, 2018 3,000.00
Mar 31, 2018 3,000.00
Dec 31, 2017 3,000.00
Sep 30, 2017 3,000.00
Jun 30, 2017 3,000.00
Mar 31, 2017 3,000.00
Dec 31, 2016 2,000.00
Sep 30, 2016 3,000.00
Jun 30, 2016 3,000.00
Mar 31, 2016 3,000.00
Dec 31, 2015 3,000.00